Stanford researchers have developed a non-invasive method of assessing chromosomal composition in human embryos at the blastocyst stage, thus potentially improving chances of success following in vitro fertilization (IVF).
Stanford researchers have developed methods for genetic and epigenetic diagnosis of embryos to determine those of which are more likely to be chromosomally normal and advance in development. This assessment method allows selection of healthier embryos for implantation.
Researchers at Stanford have developed the paperfuge- an ultra-low cost (20 cents), light weight (2g) field portable centrifuge (125,000 rpm; 30,000 g RCF) made out of paper that runs on human power.
Stanford researchers have developed a portable particle accelerator – the SLAC Piezoelectric Accelerator Neutron Source (SPAN). When combined with an ion source and a deuterated target, this piezoelectric, high-voltage generator makes a compact neutron generator system.
Engineers in Prof. James Harris' laboratory have developed a compact optics and microfluidics device to continuously monitor the hemostatic state of patients undergoing heart surgery, dialysis or other procedures.
Engineers in Prof. Shan Wang's laboratory have developed a patented magnetic sifter device for high throughput cell sorting. This technology employs magnetic nanobead probes to tag cells of interest from raw samples.
Researchers in Prof. Irving Weissman's lab have developed and patented antibodies and methods to prevent the formation of teratomas from human pluripotent stem cells used for regenerative medicine, cell therapy or research.
Researchers in Prof. Hemamala Karunadasa's laboratory have developed inexpensive, robust, high capacity hybrid materials for reversible or irreversible capture of halogens (chlorine, bromine, and iodine gas).
Researchers at Stanford have developed methods to identify, isolate, and use specific progenitor cell populations to generate adipose tissue and functional blood vessels in vivo.
Researchers in Prof. Gerald Crabtree's laboratory have identified the pathological mechanism for synovial sarcoma (SS) that could be used to develop targeted therapeutics. This approach aims to reverse the effects of the SS18-SSX fusion protein (the hallmark of human SS).
Researchers in Prof. Gerald Crabtree's laboratory have developed a method for identifying cancer patients that are likely to benefit from treatment with topoisomerase IIa (TOP2A) inhibitors.
Stanford researchers at the Airan Lab have developed a new method for robust and spatiotemporally precise non-invasive neuromodulation that could transform both basic and clinical neuroscience.
Researchers in Dr. Christina Smolke's lab have generated novel RNA aptamer sensors that can be used to regulate gene expression in response to the clinically relevant drug folinic acid.
This light-weight, hand-held, mechanical microfluidic device is designed to perform complex protocols in low resource settings without a power source or external control element. Developed by researchers in Prof.
Dr. Mark Kay and colleagues have created antibiotic-selectable, non-silencing plasmid vectors that can be prepared by conventional methods and provide persistent high levels of transgene expression.